Stefano Portolano
Amministratore Delegato presso Azafaros BV
Posizioni attive di Stefano Portolano
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Azafaros BV
 Azafaros BV Pharmaceuticals: MajorHealth Technology Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands. | Direttore/Membro del Consiglio | 30/06/2021 | - |
| Amministratore Delegato | 30/06/2021 | - |
Storia della carriera di Stefano Portolano
Formazione di Stefano Portolano
| Università degli Studi di Napoli Federico II | Doctorate Degree |
Statistiche
Distribuzione geografica
| Paesi Bassi | 2 |
| Italia | 2 |
Posizioni
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Azafaros BV
Azafaros BV Pharmaceuticals: MajorHealth Technology Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands. | Health Technology |
- Borsa valori
- Insiders
- Stefano Portolano
- Esperienza
